---
id: aga-celiac-disease-2024
title: "AGA 2024 Clinical Practice Update: Diagnosis and Management of Celiac Disease"
short_title: "AGA Celiac Disease 2024"

organization: American Gastroenterological Association
collaborators: null
country: US
url: https://www.gastro.org/guidelines
doi: null
pmid: null
open_access: true

specialty: gastroenterology
guideline_type: clinical-practice
evidence_system: AGA
conditions:
  - celiac disease
  - gluten sensitivity
  - malabsorption
tags:
  - TTG-IgA
  - gluten-free diet
  - villous atrophy
  - duodenal biopsy
  - HLA-DQ2

publication_date: 2024-03-01
previous_version_date: 2019-07-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 AGA clinical practice update on the diagnosis and management of celiac disease in adults.

## Key Recommendations

### Who to Test
- Chronic diarrhea, malabsorption, bloating, iron deficiency anemia, weight loss.
- First-degree relatives of celiac patients.
- Type 1 diabetes, autoimmune thyroid disease, Down syndrome, Turner syndrome.
- Unexplained elevated transaminases, osteoporosis, dermatitis herpetiformis.

### Diagnosis
- **Serology (While on Gluten-Containing Diet)**:
  - **IgA-TTG (Tissue Transglutaminase IgA)**: First-line test.
  - **Total IgA Level**: To exclude IgA deficiency (which would cause false-negative).
  - **If IgA-Deficient**: Use IgG-based tests (DGP-IgG, TTG-IgG).
  - **Endomysial Antibodies (EMA-IgA)**: Confirmatory if TTG borderline.

- **Duodenal Biopsy**: Recommended to confirm diagnosis in adults.
  - Obtain â‰¥4-6 biopsies from distal duodenum/duodenal bulb.
  - Histology: Villous atrophy, crypt hyperplasia, intraepithelial lymphocytosis (Marsh classification).

- **HLA Testing (DQ2/DQ8)**: High negative predictive value. If negative, celiac disease is very unlikely.

### Treatment
- **Strict Gluten-Free Diet (GFD)**: Lifelong elimination of wheat, barley, rye.
- **Dietitian Consultation**: Essential for education and adherence.
- **Nutritional Support**: Correct deficiencies (iron, B12, folate, vitamin D, calcium).

### Follow-Up
- Repeat TTG-IgA at 6-12 months to confirm serologic response.
- Persistent symptoms: Assess dietary compliance, consider repeat biopsy, evaluate for refractory celiac disease or alternative diagnoses.

### Non-Responsive / Refractory Celiac Disease
- Rule out ongoing gluten exposure (most common cause).
- Refractory celiac disease Type I/II requires specialist management.
